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Detection of fungal DNA in lysis–centrifugation blood culture for the
diagnosis of invasive candidiasis in neonatal patients
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Abstract
We report data concerning the detection of fungal DNA directly from lysis–centrifugation blood culture to assess its value in the detec-
tion of fungaemia in 86 of the 347 patients admitted to the neonatal intensive-care unit between January 2009 and December 2010.
The sensitivity and speciﬁcity of the PCR were 87.5% and 98.5%, respectively, with a positive predictive value of 93.3% and a negative
predictive value of 97.1%. Detection of fungal DNA directly from blood culture Isolator 1.5 microbial tubes, without prior cultivation, is
a promising approach for the rapid detection of Candida spp. in neonates with suspected candidaemia.
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Abstract
We analysed the 12-week virological response to protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitor (NNRTI)
therapy in 1108 patients carrying B or non-B human immunodeﬁciency virus (HIV)-1 subtypes with matched resistance mutation pat-
terns. Response rates were not signiﬁcantly different for non-B and B subtypes stratiﬁed for treatment status (51.5% vs. 41.5% in naı¨ve
patients; 46.7% vs. 38.7% in experienced patients) or regimens (46.9% vs. 39.7% with PI; 56.7% vs. 40% with NNRTI). No difference in
response was detected in patients harbouring B and non-B subtypes with any resistance proﬁle. Further studies are advisable to fully
test this approach on larger datasets.
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